Drug Topics
NOVEMBER 2, 2023
Providers create a disparity themselves by choosing not to treat obesity because stigma has led them to believe that patients with obesity are not sick enough to warrant medical intervention.
PharmaVoice
NOVEMBER 2, 2023
From Merck and J&J to AbbVie and Eisai, the oncology field has stayed consistently devoted to churning out important therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 2, 2023
Care home staff play a role in transmission to elderly residents by bringing flu in from their communities, especially in winter. Vaccination can combat this risk, but not all care workers get flu shots.
PharmaVoice
NOVEMBER 2, 2023
A challenging funding environment and lack of partnering deals have contributed to the market's ongoing troubles.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 2, 2023
Findings from the study highlight potential unmet needs had by patients with mild psoriasis seeking treatment.
Pharmacy Times
NOVEMBER 2, 2023
Pharmacy Times will be at the American Society for Nephrology’s (ASN) 2023 Kidney Week Annual Meeting in Philadelphia, Pennsylvania, from November 2 to 5.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 2, 2023
The increased costs for patients with recurrent hyperkalemia were driven by the increased inpatient medical cost of additional time spent in the hospital following recurrence.
Drug Topics
NOVEMBER 2, 2023
Panelists at an AMCP Nexus session provided a rundown of the 340B discount program and addressed whether it's actually working to lower out-of-pocket costs for patients.
STAT
NOVEMBER 2, 2023
A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine , a common medication used to treat opioid addiction, via telehealth. The measure, known as the Telehealth Response for E-prescribing Addiction Therapy Services Act — TREATS, for short — would permanently extend a temporary, Covid-era policy that allowed patients to receive buprenorphine remotely, without an in-person visit.
Pharmacy Times
NOVEMBER 2, 2023
An analysis of the REVOLUTIONIZE II study data showed that there is an unmet need for long-term outpatient treatment of hyperkalemia in patients with CKD.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 2, 2023
Our minds have a weird and wondrous way of transporting us to other places and times. You might find yourself, for instance, immersed in the vivid world of a novel, or reminiscing about a potluck with close friends. These reveries can feel magical, but they’re the result of complex electric signals zipping through the brain. Now a new study shows we’re not the only ones with an imagination.
Pharmacy Times
NOVEMBER 2, 2023
Outside of dialysis and transplantations, implantable artificial kidneys present an additional option for treating kidney disease, according to an expert.
STAT
NOVEMBER 2, 2023
WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications. The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov. 8 , and includes policy on a broad range of health care priorities, including substance abuse and mental health care, and extensions to provider pay.
Pharmacy Times
NOVEMBER 2, 2023
How pharmacy teams can remove cost barriers to cardiac care.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 2, 2023
There is a persistent shortage of primary care doctors in the rural United States. Specialists, like OB-GYNs and endocrinologists, are even harder to access. According to the National Rural Health Association, there are only 30 specialists for every 100,000 residents in rural areas, compared to 263 per 100,000 in urban communities. These shortages mean that many patients must routinely drive long distances to see their doctors, or simply go without care.
Fierce Healthcare
NOVEMBER 2, 2023
YouTube will now limit repeated recommendations of videos about ideal standards for teens, who the platform said are susceptible to forming negative beliefs about themselves after their repeated vi | The company’s Youth and Families Advisory Committee, a team of independent experts in child development, digital learning, children’s media and more, helped YouTube identify categories of content that may be harmless as a single video but could be problematic for some teens if viewed repeatedly.
STAT
NOVEMBER 2, 2023
Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ.
Pharmacy Times
NOVEMBER 2, 2023
The approval marks the first major innovation in the United States for the treatment of erosive GERD in over 30 years.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
NOVEMBER 2, 2023
WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday. A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.
Fierce Healthcare
NOVEMBER 2, 2023
The Centers for Medicare & Medicaid Services has dropped the final rule to remedy the invalidated 340B-acquired drug payment policy for calendar years 2018 to 2022. | In a statement, American Hospital Association president and CEO Rick Pollack commended the coming repayment to 340B hospitals, but condemned HHS' choice to cut Medicare rates.
STAT
NOVEMBER 2, 2023
Over the past five years, two unique federal efforts have collected the health records of millions of Americans. They’ve assembled billions of clinical observations, medication logs, lab results, and more with the goal of supercharging public health research. Now, their dramatically different approaches to data sharing are coming together to put citizens’ real-world health information to work.
Fierce Healthcare
NOVEMBER 2, 2023
When the Affordable Care Act was passed, some feared its changes could lead many employers to drop health coverage altogether. | When the Affordable Care Act was passed, some feared its changes could lead many employers to drop health coverage altogether.
European Pharmaceutical Review
NOVEMBER 2, 2023
While unsolicited and burdensome, medicine shortages are an obstacle faced by the pharmaceutical industry. In 2023, a combination of factors, including increased demand (particularly for critical medicines), economic inflation, as well as international geopolitical unrest, has led to Europe’s supply chain being acutely affected. Consequently, regulators, trade groups and other organisations have worked to prevent and alleviate medicine shortages in the region.
Fierce Healthcare
NOVEMBER 2, 2023
Hospitals’ financials dipped in September as volumes dipped “across the board” and labor expenses inched upward, according to Kaufman Hall’s monthly sector report. | Reduced month-over-month volume metrics and a bump in labor expenses chipped at the hospital sector's operating margins, according to the healthcare consulting firm.
pharmaphorum
NOVEMBER 2, 2023
12 Questions with Jenny Reid-Young Mike.
STAT
NOVEMBER 2, 2023
Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries.
pharmaphorum
NOVEMBER 2, 2023
Sangamo sheds staff once again in another retreat Phil.
Pharmaceutical Technology
NOVEMBER 2, 2023
Memo’s fast track-designated candidate is currently in a Phase II trial for BKV infection, with a data readout expected in 2024.
Drug Store News
NOVEMBER 2, 2023
At NACDS’ Total Store Expo, DSN caught up with iA’s Tom Utech and Bobbi Jamriska about what’s new with the pharmacy automation solutions company.
STAT
NOVEMBER 2, 2023
When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Biotech consultant Frank David joins us to explain the wild world of subgroup analyses and how to discern science from spin.
pharmaphorum
NOVEMBER 2, 2023
Novo Nordisk shrugs off supply issues with record sales Phil.
Drug Store News
NOVEMBER 2, 2023
Pantene is kicking off its partnership with Tini Stoessel by naming her its newest Healthy Hair Ambassador and also sharing the plans to sponsor her first tour in the United States.
pharmaphorum
NOVEMBER 2, 2023
Samay’s AI-enabled wearable ‘can diagnose COPD’ Phil.
Expert insights. Personalized for you.
503 
Let's personalize your content